Ctxr sec filings

Author: yscz

August undefined, 2024

Webctxrex1012.htm exhibit 10.12 placement agent's unit warrants neither these securities nor the securities issuable upon exercise of these securities have been registered with the …

Citius Pharmaceuticals - CTXR Institutional Ownership

WebSEC Filings for Citius Pharmaceuticals Inc (CTXR) including Annual 10-K and Quarterly 10-Q Reports. Your browser of choice has not been tested for use with Barchart.com. If … WebCTXR / Citius Pharmaceuticals Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5 EXTENDED Overview Owners Insiders Short Interest Options Filings Financials … dallas district clerk search

CTXR SEC Filings - Citius Pharmaceuticals Inc - Annual Report, …

WebAug 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Thursday, June 30, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu Aug 11 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. WebJan 9, 2024 · Filings & Forms. All companies, foreign and domestic, are required to file registration statements, periodic reports, and other forms electronically through EDGAR. … WebDec 17, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-K Annual report for the fiscal year ending Monday, September 30, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-K Annual Report Mon Dec 16 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. dallas divorce lawyers for men

Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 8-K Material Event …

Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly …

WebJun 22, 2024 · Citius Pharmaceuticals, Inc. (OTCMKTS:CTXR) Files An 8-K Submission of Matters to a Vote of Security Holders Item 3.03 – Material Modification to Rights of … WebApr 6, 2024 · SEC Filings Short Interest Social Media Get Citius Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CTXR and its competitors with MarketBeat's FREE daily newsletter. CTXR Media Mentions By Week CTXR Media Sentiment CTXR News Sentiment 0.40 0.51 Average Medical News … birch grove software dallasWebCitius Pharmaceuticals Inc (NASDAQ:CTXR) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position … birch grove software adon1

"WebFeb 10, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Saturday, December 31, 2024 " - Ctxr sec filings

Ctxr sec filings

Yahoo Finance - Stock Market Live, Quotes, Business & Finance …

WebFind the latest Citius Pharmaceuticals, Inc. (CTXR) stock quote, history, news and other vital information to help you with your stock trading and investing. WebView 13F filing holders of Citius Pharmaceuticals Inc. 13F filings are submitted quarterly to the SEC by hedge funds and other investment managers. WhaleWisdom. 13F Data. Latest 13F Filings; 13F Heat Map; 13F Trend Charts; 13F Stats; Stock 13F Stats; Stock Earnings and Events Calendar ... Funds Holding CTXR (via 13F filings)

Did you know?

WebApr 3, 2024 · Ticker: CTXR CIK: 1506251 Form Type: 8-K Corporate News Accession Number: 0001213900-23-026265 Submitted to the SEC: Mon Apr 03 2024 4:05:20 PM … WebThis table shows the interest rate that must be paid by a short seller of US:CTXR to the lender of that security. This fee is shown as an annual percentage rate (APR). Lenders are funds or individuals that own the …

WebMay 14, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly report for the period ending Tuesday, March 31, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu May 14 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. WebThese reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Citius Pharmaceuticals Inc

WebDec 22, 2024 · SEC Filings Citius Pharmaceuticals, Inc. (CTXR) 8-K Material Event Thu Dec 22 2024 Earnings Press Release 8-K Corporate News Citius Pharmaceuticals, Inc. … WebInstitutional Ownership and Shareholders Citius Pharmaceuticals Inc (US:CTXR) has 94 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). …

WebApr 10, 2024 · A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CTXR shares currently have a short interest ratio of 13.0. Learn More on Citius Pharmaceuticals's short interest ratio.

WebSep 28, 2024 · Ticker: CTXR CIK: 1506251 Form Type: 8-K Corporate News Accession Number: 0001213900-22-059746 Submitted to the SEC: Wed Sep 28 2024 4:05:14 PM EST Accepted by the SEC: Wed Sep 28 2024 Period: Wednesday, September 28, 2024 Industry: Pharmaceutical Preparations Events: Financial Exhibit; Other Events; External … birchgrove public school preschoolWebFeb 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly report for the period ending Thursday, December 31, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu Feb 11 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. birchgrove pub cardiffWebCommon stock, $0.001 par value CTXR The Nasdaq Capital Market ￻ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ dallas district office eeocWebAug 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Thursday, June 30, 2024 dallas divorce attorneys for womenWebFind the latest SEC Filings data for Citius Pharmaceuticals, Inc. Common Stock (CTXR) at Nasdaq.com. Citius Pharmaceuticals, Inc. Common Stock (CTXR) SEC Filings … dallas direct flights to europeWebNov 15, 2024 · Contact Us. Citius Pharmaceuticals, Inc. 11 Commerce Drive, First Floor Cranford, NJ 07016 908-967-6677 [email protected]. follow us on twitter birchgrove surgery addressWebFeb 10, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 8-K Material Event for the period ending Friday, February 10, 2024 dallas divorce lawyers free consultation